Vaccine
Volume 38, Issue 26

Research article Abstract only
Vaccine indicator and reminder band to improve demand for vaccination in Northern Nigeria: A qualitative evaluation of implementation outcomes
Chisom Obi-Jeff, Noor Sabah Rakhshani, Jamila Ibiye Bello-Malabu, Chike Nwangwu, … Chizoba Wonodi
Pages 4191-4199

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 13 June 2020)

Open Access Article
Coverage and Timeliness of Birth Dose Vaccination in Sub-Saharan Africa: A Systematic Review and Meta-Analysis
by Oumar Bassoum , Moe Kimura , Anta Tal Dia , Maud Lemoine and Yusuke Shimakawa
Vaccines 2020, 8(2), 301; https://doi.org/10.3390/vaccines8020301 – 11 Jun 2020
Abstract
Background: Depending on the epidemiological context of each country, three vaccines are recommended by the World Health Organization (WHO) to be administered as soon as possible after birth (birth vaccines); namely, BCG, zero dose of oral polio vaccine (OPV0), and birth dose

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 13 June 2020)

Open Access Article
Influenza Vaccination Experiences of Pregnant Women as a Predictor of the Intention to Become Vaccinated in Future Pregnancies in Spain
by Noelia Rodríguez-Blanco , José Tuells and Andreu Nolasco
Vaccines 2020, 8(2), 291; https://doi.org/10.3390/vaccines8020291 – 09 Jun 2020
Viewed by 256
Abstract
A good perception of the vaccines administered during pregnancy favors immunization coverage, which is still not optimal for the influenza vaccine. To understand the predisposition towards vaccination in future pregnancies, a study was performed that evaluated the experiences of women with the vaccine

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

No new digest content identified.

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 13 June 2020
Health
Coronavirus Researchers Tried to Warn Us
Before the pandemic hit, they struggled to get funding that might have hastened treatments for COVID-19.
Charles Schmidt and Undark
The now-prophetic words could be found at the end of a research paper published in the journal Clinical Microbiology Reviews in October of 2007: “The presence of a large reservoir of SARS-CoV-like viruses in horseshoe bats, together with the culture of eating exotic mammals in southern China, is a time bomb.”
The warning—made nearly 13 years ago and more than four years after the worrying first wave of severe acute respiratory syndrome, or SARS, killed nearly 800 people globally—was among the earliest to predict the emergence of something like SARS-CoV-2, the virus behind the current COVID-19 pandemic.
Many other warnings would follow…

Ideas
The Virus Will Win
Americans are pretending that the pandemic is over. It certainly is not.
June 12, 2020
Yascha Mounk, Contributing writer at The Atlantic
A second wave of the coronavirus is on the way. When it arrives, we will lack the will to deal with it. Despite all the sacrifices of the past months, the virus is likely to win—or perhaps it would be more accurate to say that it already has.
In absolute terms, the United States has been hit harder than any other country. About a quarter of worldwide deaths have been recorded on these shores. And while the virus is no longer growing at an exponential rate, the threat it poses remains significant: According to a forecasting model by Morgan Stanley, the number of American cases will, if current trends hold, roughly double over the next two months.
But neither the impact of mass protests over police brutality nor the effect of the recent reopening of much of the country—including the casinos in Las Vegas—is reflected in the latest numbers. It can take at least 10 days for people to develop symptoms and seek out a test, and for the results to be aggregated and disseminated by public-health authorities.
Even so, the disease is slowly starting to recede from the public’s attention. After months of dominating media coverage, COVID-19 has largely disappeared from the front pages of most national newspapers. In recent polls, the number of people who favor “reopening the economy as soon as possible” over “staying home as long as necessary” has increased. And so it is perhaps no surprise that even states where the number of new infections stands at an all-time high are pressing ahead with plans to lift many restrictions on businesses and mass gatherings…

BBC
http://www.bbc.co.uk/
Accessed 13 June 2020
[No new, unique, relevant content]

The Economist
http://www.economist.com/
Accessed 13 June 2020
[No new, unique, relevant content]

Financial Times
http://www.ft.com/home/uk
Accessed 13 June 2020
Coronavirus pandemic
Covid-19 cases spike in several US states | DC Lockdown Diary
June 13, 2020

Coronavirus pandemic

OECD warns of deepest economic scars in peacetime for a century
June 10, 2020

Coronavirus pandemic
Anthony Fauci warns pandemic has further to run
June 9, 2020

Forbes
http://www.forbes.com/
Accessed 13 June 2020
Jun 12, 2020
The Hideous Truths Of Testing Vaccines On Humans
Sixty years ago, a monstrous hepatitis experiment was performed on mentally disabled children at Willowbrook State School that raises serious ethical questions about vaccine challenge trials for Covid-19.
By Leah Rosenbaum Forbes Staff

Jun 12, 2020
Coronavirus Vaccine Options Would Help The Economy
Corporations with cash who would benefit greatly from a vaccine should use their resources to speed development. Buying vaccine options would do that.
By Bill Conerly Senior Contributor

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 13 June 2020
Snapshot June 13, 2020
Democracy Versus the Pandemic
The downward democratic spiral can still be reversed, but it will require mobilized civil societies, effective democratic management of the health crisis, and a renewal…
Larry Diamond

Comment July/August 2020
When the System Fails
The pandemic has revealed both the limits of the existing multilateral system and the horrific costs of the system’s failure.
Stewart Patrick

Foreign Policy
http://foreignpolicy.com/
Accessed 13 June 2020 | [No new, unique, relevant content]
[No new, unique, relevant content]

The Guardian
http://www.guardiannews.com/
June 13, 2020
Fauci says US might not see ‘second wave’ of Covid-19 cases …

New Yorker
http://www.newyorker.com/
Accessed 13 June 2020
U.S. Journal
Can Coronavirus Contact Tracing Survive Reopening?
Massachusetts created a pioneering program to track COVID-19 cases. Its challenges are multiplying as the state reopens.
By Benjamin Wallace-Wells
June 12, 2020

Daily Comment
What the W.H.O. Meant to Say About Asymptomatic People Spreading the Coronavirus
The W.H.O. official’s words were terribly misleading, but the organization quickly clarified that social distancing and masks are not just for those who clearly have symptoms.
By Amy Davidson Sorkin
June 11, 2020

New York Times
http://www.nytimes.com/
Accessed 13 June 2020
Sunday Review
Don’t Leave the W.H.O. Strengthen It.
The organization is still the world’s best hope for fighting pandemics.
By The Editorial Board June 13, 2020

Science
Guaranteed Ingredient in Any Coronavirus Vaccine? Thousands of Volunteers
Two sisters in Missouri were among the first to have an unproven coronavirus vaccine injected in their bodies. If it makes it to market, it would also be the first DNA vaccine for any disease.
By Heather Murphy June 13, 2020

Business

AstraZeneca Agrees to Make COVID-19 Vaccine for Europe
Drugmaker AstraZeneca struck a deal Saturday to supply up to 400 million doses of an experimental COVID-19 vaccine to European Union countries, the latest in a series of agreements as scientists, governments and pharmaceutical companies race to combat the virus.
By The Associated Press June 13, 2020

World
Coronavirus Live Updates: Chile’s Health Minister Resigns Amid Criticism
China closed a market that handles 90 percent of Beijing’s fresh fruit and vegetables after dozens of people tested positive. Florida sees a record number of new cases for the third day in a row.

Opinion
Could Trump Turn a Vaccine Into a Campaign Stunt?
In a desperate search for a boost, he could release a coronavirus vaccine that has not been shown to be safe and effective as an October surprise.
By Ezekiel J. Emanuel and Paul A. Offit

Washington Post
https://www.washingtonpost.com/
Accessed 13 June 2020
Can old vaccines from science’s medicine cabinet ward off coronavirus?
Carolyn Y. Johnson and Steven Mufson · Health · Jun 11, 2020

Think Tanks et al

Brookings
http://www.brookings.edu/
Accessed 13 June 2020
Op-Ed
COVID-19 may ultimately strengthen Latin America’s democracies, not destroy them
Eduardo Levy Yeyati and Andrés Malamud
Thursday, June 11, 2020

Global Economy
Less globalization, more multilateralism
Kemal Derviş
Wednesday, June 10, 2020

Center for Global Development [to 13 June 2020]
http://www.cgdev.org/page/press-center
Accessed 13 June 2020
June 12, 2020
Evidence-Based Decision Making During COVID-19: How to Navigate Extreme Uncertainty and Urgency
Evidence-based policy generation is an aspiration more than reality at the best of times. With COVID-19 generating extreme uncertainty and urgency of action across the world, it has become harder than ever. This blog considers three areas where both researchers and policymakers need to engage more effectively: asking better questions; being clearer about how well we can answer them; and broadening collaboration and challenge.
Ranil Dissanayake

June 9, 2020
What Does Success Look Like for a COVID-19 Vaccine? Improving Portfolio Level Understanding
Around the world COVID-19 and the policy responses to it are causing unprecedented disruptions of life and wellbeing. As scientists and governments around the world race to develop a vaccine at scale, we take a look at what a portfolio approach entails and why it is so important.
Anthony McDonnell, Prashant Yadav and Kalipso Chalkidou

June 8, 2020
In the Race to Develop a Vaccine For COVID-19, Is a Pull for R&D Essential or Optional?
The global race to develop a COVID-19 vaccine is far from conventional. An effective vaccine would offer one of the few credible exit paths from the world’s worst public health and economic crisis in recent history. Is a pull for R&D essential or optional?
Kalipso Chalkidou et al.

Chatham House [to 13 June 2020]
https://www.chathamhouse.org/
[No new relevant content]

CSIS
https://www.csis.org/
Accessed 13 June 2020
[No new relevant content]

Council on Foreign Relations
http://www.cfr.org/
Accessed 13 June 2020
[No new relevant content]

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 13 June 2020
[No new relevant content]

Milestones :: Perspectives :: Research

World leaders make historic commitments to provide equal access to vaccines for all
:: The Global Vaccine Summit, hosted by the UK, raises US$ 8.8 billion from 32 donor governments and 12 foundations, corporations and organisations to immunise 300 million children and support the global fight against COVID-19
:: US$ 567 million also raised for new innovative financing instrument to provide access to COVID-19 vaccines for low- and middle-income countries
:: Boris Johnson: “Together we rise to fulfil the greatest shared endeavour of our lifetime – the triumph of humanity over disease, now and for the generations that follow.”

London, 4 June 2020 – World leaders have pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far exceeding the target of US$ 7.4 billion.

The funding will help immunise 300 million more children in the world’s poorest countries against diseases like measles, polio and diphtheria by the end of 2025. It will also support health systems to withstand the impact of coronavirus and maintain the infrastructure necessary to roll out a future COVID-19 vaccine on a global scale.

The pledges were made at the Global Vaccine Summit 2020, hosted by UK Prime Minister Boris Johnson. Representatives from 52 countries, including 35 Heads of State, joined leaders from global health organisations, the private sector, vaccine manufacturers and civil society organisations to support the Vaccine Alliance’s work protecting almost half the world’s children against deadly, preventable infectious diseases..

The UK remains the Vaccine Alliance’s largest donor, pledging the equivalent of £330 million per year over the next five years. Other top donors include the Bill & Melinda Gates Foundation, Norway, Germany and the United States. Eight countries made their first ever pledge to Gavi, including Bhutan, Burkina Faso, Cameroon, Finland, Greece, New Zealand, Portugal and Uganda…

…Over the next five years, we will also see the largest investment in immunisation ever made by lower-income countries.

Gavi-supported countries will contribute US$ 3.6 billion towards the cost of buying vaccines – more than double the amount for the 2016-2020 period and more than 40% of the total estimated cost of supplying vaccines to these countries. They are also expected to invest around US$ 6 billion in immunisation service delivery costs over the same period. The dire economic effects of the COVID-19 pandemic may, however, disrupt these estimates.

Gavi’s market-shaping efforts to make life-saving vaccines more affordable have seen a 21% price reduction for fully immunising a child with pentavalent, pneumococcal and rotavirus vaccines – from $20.01 in 2015 to $15.90 in 2018…

…The world’s biggest vaccine manufacturers also committed to continue supplying the billions of doses needed to continue increasing vaccine coverage across Africa and Asia. The Vaccine Alliance is one of the world’s largest and most successful public-private partnerships, and the wider private sector continued to show support for its mission with the announcement of more than US$ 70 million of new pledges and partnerships, bringing new technology, networks and expertise to help solve some of global health’s most intractable problems.

“On behalf of the countless vaccinators, supply chain workers, programme managers and the many, many others that work tirelessly every day to ensure children in vulnerable countries continue to receive lifesaving vaccines – thank you,” said Dr Ngozi Okonjo-Iweala, Gavi Board Chair. “We have made incredible progress over the past two decades improving vaccine coverage and reducing child mortality across Africa and Asia. This funding will give countries new hope that, despite the devastating impact of COVID-19, this progress can be sustained and built on. The Alliance will now get to work making this happen.”

The Global Vaccine Summit also saw the launch of the Advance Market Commitment for COVID-19 Vaccines (Covax AMC), a new innovative financing instrument to provide access to COVID-19 vaccines for low- and middle-income countries. This is the first building block towards a global mechanism to ensure equitable access to future COVID-19 vaccines. US$ 567 million was raised today in initial seed money for the AMC from 12 donors…

::::::

Bill & Melinda Gates Foundation pledges $1.6 billion to Gavi, the Vaccine Alliance, to protect the next generation with lifesaving vaccines
JUNE 04, 2020
Global leaders unite to safeguard 300 million more children from disease and mitigate consequences of COVID-19

::::::

Gavi launches innovative financing mechanism for access to COVID-19 vaccines
:: Gavi Advance Market Commitment for COVID-19 Vaccines (Gavi Covax AMC) launched at Global Vaccine Summit 2020 draws strong support, early commitments from global leaders 
:: New financing mechanism, aimed at supporting affordable access for developing countries, is first building block in broader initiative to create a Covax Facility for global access to eventual COVID-19 vaccines
:: Ngozi Okonjo-Iweala: “The Gavi Covax AMC increases the likelihood that when we have a successful vaccine or vaccines, it will be available in sufficient quantities and affordable to developing countries.”

Geneva, 04 June 2020 – Gavi, the Vaccine Alliance today launched the Gavi Advance Market Commitment for COVID-19 Vaccines (Gavi Covax AMC), a new financing instrument aimed at incentivising vaccine manufacturers to produce sufficient quantities of eventual COVID-19 vaccines, and to ensure access for developing countries.

The Gavi Covax AMC is being launched with an initial goal of raising US$ 2 billion; enough for Gavi-supported countries to immunise health care workers as well as high-risk individuals, and create a flexible buffer of doses to be deployed where needed most.

It will not be a stand-alone financing instrument but rather represents the first building block in broader efforts to develop a COVID-19 Global Vaccine Access Facility (Covax Facility) aimed at ensuring equitable access to COVID-19 vaccines for all countries, at all levels of development, that wish to participate.

The Gavi Covax AMC is inspired by similar mechanisms that have successfully secured equitable global access to pneumococcal and Ebola vaccines. By providing volume guarantees for specific candidates before they are licenced, as well as market-wide guarantees, the Gavi Covax AMC will encourage manufacturers to make investments in production capacity. This in turn increases supply availability and reduces the amount of time it takes for licenced vaccines to become available, particularly to the poorest countries around the world.

“Today’s launch moves us one step closer to the essential vision of equitable access for all,” said Dr Ngozi Okonjo-Iweala, Chair of the Gavi Board. “By de-risking the cost of investing in high volumes of manufacturing against an unknown outcome – and making sure those investments are made now – the Gavi Covax AMC increases the likelihood that when we have a successful vaccine or vaccines, it will be available in sufficient quantities and affordable to developing countries…

::::::

HPV vaccine manufacturers commit to provide enough supply to immunize at least 84 million girls in Gavi countries
:: On the eve of the Global Vaccine Summit 2020, five manufacturers commit to increasing and prioritising HPV vaccine supply to Gavi-supported countries, which have among the highest cervical cancer burdens in the world
:: Gavi estimates that up to 84 million girls in the poorest countries could receive HPV vaccines in the next 5-year period, averting 1.4 million future cervical cancer deaths
:: Dr Seth Berkley: “We are extremely grateful to MSD, GSK, Innovax, Serum Institute of India Pvt. Ltd. and Walvax for these commitments, which should have a profound impact on women’s lives”

Geneva, 03 June 2020 – Vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India Pvt. Ltd. (SII) and Walvax have pledged to ramp up human papillomavirus (HPV) vaccine supply availability for Gavi-supported countries, ahead of tomorrow’s Global Vaccine Summit 2020.

This commitment is part of an ongoing UNICEF-led tender that aims to enable Gavi to dramatically increase its reach from 50 million girls, as initially planned, to 84 million girls during the next five-year period, leading to the prevention of an estimated 1.4 million future deaths from cervical cancer…

Milestones :: Perspectives :: Research

WHO welcomes crucial new funding for vaccines
4 June 2020 News release
WHO welcomes funding commitments made at today’s Global Vaccine Summit, hosted virtually by the UK government. The Summit is Gavi, the Vaccine Alliance’s third pledging conference and follows the successful Berlin summit in January 2015.

The new pledges will enable Gavi to protect the next generation and reduce disease inequality by reaching an additional 300 million children with vaccines by 2025.
“Thanks to vaccines, hundreds of millions of deaths have been prevented. Polio has been pushed to the brink of eradication, and just in the past few years new vaccines have become available for Ebola and malaria,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.

“But vaccines only realize their true power when they are deployed to protect the poorest and most vulnerable. The COVID-19 pandemic is unravelling many of the gains we have made, with vaccination campaigns for polio, cholera, measles, diphtheria, and meningitis.”

The bold funding commitments mean that the Gavi Alliance will be better able to maintain immunization in lower-income countries, mitigating the impact of the COVID-19 pandemic. They will also help strengthen health systems.

The backdrop of the COVID-19 pandemic is a sobering reminder of how much individual health depends on collective health and the critical role that vaccines play in keeping the global population safe and healthy. The Summit also highlighted how important a safe, effective and equitably accessible vaccine will be in controlling COVID-19.

The Global Vaccine Summit marks 20 years since Gavi was founded. Dr Tedros added: “We join Gavi in celebrating the collective success of this great Alliance. These pledges are not just an investment in the Alliance of which we are a very proud partner; they are an advance on our shared vision of a healthier, safer and fairer world.”

EMERGENCIES

Coronavirus [COVID-19]
Public Health Emergency of International Concern (PHEIC)

Coronavirus disease (COVID-19) outbreak situation
Last update: 5 June 2020, 20:00 GMT-4
Confirmed cases :: 6 663 304
Confirmed deaths :: 392 802
Countries, areas or territories with cases :: 216

:: WHO COVID-19 Webpage: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
:: Daily WHO situation reports here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
:: WHO Coronavirus disease (COVID-2019) daily press briefings here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/press-briefings

::::::
::::::

Emergencies

Ebola – DRC+
Public Health Emergency of International Concern (PHEIC)

Government of Democratic Republic of Congo declares 11th Ebola virus disease outbreak
ADDIS ABABA, ETHIOPIA, 2 JUNE 2020. The Government of the Democratic Republic of Congo (DRC) declared a new outbreak of Ebola Virus Disease (EVD) on 31 May 2020 in Mbandaka, the country’s northwest Équateur Province. The declaration followed notification by the Équateur provincial health authorities of community deaths on 23 and 30 May 2020.
This is the 11th EVD outbreak in the DRC and it has already claimed four lives and infected four other people in the community. The outbreak began at a time when experts were close to declaring an end to the 10th EVD outbreak in North Kivu Province, and when countries are fighting hard to control the COVID-19 pandemic.
The DRC Ministry of Health is currently establishing a coordination and response mechanism to effectively contain the outbreak…

UNICEF Press release
Ebola resurfaces in Équateur Province, north-western Democratic Republic of the Congo
15-year-old girl among five victims of new outbreak as country battles Ebola, COVID-19 and measles
01/06/2020

Ebola Outbreak in DRC 95: 02 June 2020
[Excerpts]
Situation Update WHO Health Emergencies Programme Page 2
From 24 to 31 May 2020, no new confirmed cases of Ebola virus disease (EVD) have been reported in Ituri, North Kivu and South Kivu provinces of the Democratic Republic of the Congo. The source of infection of the cluster reported in April 2020 remains unconfirmed….

::::::
::::::

Emergencies

POLIO
Public Health Emergency of International Concern (PHEIC)

Polio this week as of 02 June 2020
:: After a vaccine-derived poliovirus outbreak was detected in the Philippines in 2019, health workers have been working to close a polio immunity gap present amongst some of the nation’s children. In this story, we follow Joana, a nurse working to end polio in Manila.

Summary of new viruses this week (AFP cases and ES positives):
:: Afghanistan: six cVDPV2 cases
:: Burkina Faso: two cVDPV2 cases
:: Ethiopia: one cVDPV2 case
:: Côte d’Ivoire: three cVDPV2 cases

::::::
::::::

WHO Grade 3 Emergencies [to 6 June 2020]

Democratic Republic of the Congo
:: Ebola Outbreak in DRC 95: 02 June 2020
[See Ebola above for detail]

Nigeria – No new digest announcements identified
Somalia – No new digest announcements identified
South Sudan – No new digest announcements identified
Syrian Arab Republic – No new digest announcements identified
Yemen – No new digest announcements identified

::::::

WHO Grade 2 Emergencies [to 6 June 2020]
Angola
:: Community health mobilizers on the frontlines of Angola’s COVID-19 response
04 June 2020

Afghanistan – No new digest announcements identified
Burkina Faso [in French] – No new digest announcements identified
Burundi – No new digest announcements identified
Cameroon – No new digest announcements identified
Central African Republic – No new digest announcements identified
Ethiopia – No new digest announcements identified
Iran – No new digest announcements identified
Iraq – No new digest announcements identified
Libya – No new digest announcements identified
Malawi – No new digest announcements identified
Measles in Europe – No new digest announcements identified
MERS-CoV – No new digest announcements identified
Myanmar – No new digest announcements identified
Niger – No new digest announcements identified
occupied Palestinian territory – No new digest announcements identified
Sudan – No new digest announcements identified
Ukraine – No new digest announcements identified
Zimbabwe – No new digest announcements identified

::::::

WHO Grade 1 Emergencies [to 6 June 2020]

Chad – No new digest announcements identified
Djibouti – No new digest announcements identified
Kenya – No new digest announcements identified
Mali – No new digest announcements identified
Namibia – viral hepatitis – No new digest announcements identified
Tanzania – No new digest announcements identified

::::::
::::::

UN OCHA – L3 Emergencies
The UN and its humanitarian partners are currently responding to three ‘L3’ emergencies. This is the global humanitarian system’s classification for the response to the most severe, large-scale humanitarian crises. 
Syrian Arab Republic
:: Syrian Arab Republic: COVID-19 Response Update No. 05 – 5 June 2020

Yemen
:: 02 June 2020 Yemen Humanitarian Update Issue 5 (May 2020)
:: 03 June 2020 Yemen Situation Report, 3 June 2020

::::::

UN OCHA – Corporate Emergencies
When the USG/ERC declares a Corporate Emergency Response, all OCHA offices, branches and sections provide their full support to response activities both at HQ and in the field.
CYCLONE IDAI and Kenneth – No new digest announcements identified
EBOLA OUTBREAK IN THE DRC – No new digest announcements identified

::::::
::::::

WHO & Regional Offices [to 6 June 2020]
4 June 2020 News release
WHO welcomes crucial new funding for vaccines
[See Milestones above for detail]

3 June 2020 Departmental news
World Food Safety Day 2020: UN experts in Facebook live event on 5 June 2020

2 June 2020 Statement
Statement from Dr Mike Ryan, Executive Director, WHO Health Emergencies Programme at the Yemen High-level Pledging Conference

1 June 2020 Departmental news
Basic Psychosocial Skills: A Guide for COVID-19 Responders

::::::

Weekly Epidemiological Record, 5 June 2020, vol. 95, 23/24 (pp. 257–264)
Fast-tracking WHO’s COVID-19 technical guidance to training for the frontline

::::::

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region AFRO
:: Polio eradication expertise backs Africa’s COVID-19 response 04 June 2020
Expertise in polio eradication that has put Africa on the verge of being certified free of wild poliovirus has been brought to the frontlines of COVID-19 fight. A network of responders from the World Health Organization (WHO) Polio Eradication Programme and partner organizations is providing critical resources and skills to tackle the COVID-19 pandemic.
: New Ebola outbreak detected in northwest Democratic Republic of the Congo; WHO surge…
01 June 2020

WHO Region of the Americas PAHO
No new digest content identified.

WHO South-East Asia Region SEARO
:: India elected chair of WHO’s Executive Board 22 May 2020

WHO European Region EURO
:: WHO joins forces with 17 central European countries to step up tailored COVID-19 response 05-06-2020
:: World Food Safety Day: Unsafe food continues to affect millions in Europe during COVID-19 pandemic 05-06-2020
:: Protecting nature protects health – lessons for the future from COVID-19 05-06-2020
:: Transitioning towards ‘a new normal’ must be guided by public health principles, together with economic and societal considerations 03-06-2020

WHO Eastern Mediterranean Region EMRO
:: COVID-19: Keeping Morocco’s mothers and babies safe 1 June 2020

WHO Western Pacific Region
No new digest content identified.

CDC/ACIP [to 6 June 2020]
http://www.cdc.gov/media/index.html
https://www.cdc.gov/vaccines/acip/index.html
Latest News Releases
HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing
Thursday, June 4, 2020
Today, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specifies what additional data must be reported to HHS by laboratories along with Coronavirus Disease 2019 (COVID-19) test results. The Guidance standardizes reporting to ensure that public health officials have access to comprehensive and nearly real-time data to inform decision making in their response to COVID-19. As the country begins to reopen, access to clear and accurate data is essential to communities and leadership for making decisions critical to a phased reopening.

“HHS and the entire Trump Administration are deeply concerned that COVID-19 is having a disproportionate impact on certain demographics, including racial minorities and older Americans,” said HHS Secretary Alex Azar. “High quality data is at the core of any effective public health response, and standardized, comprehensive reporting of testing information will give our public health experts better data to guide decisions at all levels throughout the crisis.”
The new reporting requirements will provide information needed to better monitor disease incidence and trends by initiating epidemiologic case investigations, assisting with contact tracing, assessing availability and use of testing resources, and anticipating potential supply chain issues.

“The requirement to include demographic data like race, ethnicity, age, and sex will enable us to ensure that all groups have equitable access to testing, and allow us to accurately determine the burden of infection on vulnerable groups,” said ADM Brett P. Giroir, MD, Assistant Secretary for Health. “With these data we will be able to improve decision-making and better prevent or mitigate further illnesses among Americans.”…

MMWR News Synopsis Friday, Jun 5, 2020
Missed Opportunities for Prevention of Congenital Syphilis — United States, 2018

Multistate Mumps Outbreak Originating from Asymptomatic Transmission at a Nebraska Wedding — Six States, August–October 2019

Evidence for Early Spread of COVID-19 Within the United States, January–February 2020 (Early release May 29, 2020)

COVID-19 Monitoring and Response Among U.S. Air Force Basic Military Trainees — Texas, March–April (Early release June 2, 2020)

Africa CDC [to 6 June 2020]
http://www.africacdc.org/
News
Press Releases
African Union rolls out Partnership to Accelerate COVID-19 Testing
4 June 2020

Press Releases
Africa CDC and Mastercard Foundation partner to deliver one million test kits, deploy 10,000 community health workers for COVID-19 response
4 June 2020

Press Releases
Government of Democratic Republic of Congo declares 11th Ebola virus disease outbreak
2 June 2020

China CDC
http://www.chinacdc.cn/en/
No new digest content identified.

National Health Commission of the People’s Republic of China
http://en.nhc.gov.cn/
News
June 6: Daily briefing on novel coronavirus cases in China
2020-06-05
On June 5, 31 provincial-level regions on the Chinese mainland as well as the Xinjiang Production and Construction Corps reported 3 new cases of confirmed infections (all are imported cases in Guangdong province), 1 new case of suspected infections (an imported case in Shanghai municipality), and no deaths…

Xi pledges continuous support for Costa Rica’s COVID-19 fight
2020-06-06

Premier calls for strengthened vaccine research
2020-06-05

Testing of nearly 9.9 million people completed in Wuhan only 0.303‱ were found asymptomatic
2020-06-04

Announcements

Paul G. Allen Frontiers Group [to 6 June 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

BARDA [to 6 June 2020]
https://www.phe.gov/about/barda/Pages/default.aspx
No new digest content identified.

BMGF – Gates Foundation [to 6 June 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
JUNE 04, 2020
Bill & Melinda Gates Foundation pledges $1.6 billion to Gavi, the Vaccine Alliance, to protect the next generation with lifesaving vaccines
Global leaders unite to safeguard 300 million more children from disease and mitigate consequences of COVID-19

Bill & Melinda Gates Medical Research Institute [to 6 June 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

CARB-X [to 6 June 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

CEPI – Coalition for Epidemic Preparedness Innovations [to 6 June 2020]
http://cepi.net/
Latest News
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
CEPI and CSL will fund the development and manufacture of UQ’s “molecular clamp” enabled vaccine against COVID-19.
COVID-19
05 Jun 2020

CEPI partners with AstraZeneca to manufacture 300 million globally accessible doses of COVID-19 vaccine
CEPI will invest a total of up to $383m in this partnership to support the manufacture the AZD1222 vaccine candidate.
COVID-19
04 Jun 2020

CEPI awards up to US $14.1 million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
CEPI to partner with Bharat Biotech and IVI to advance clinical development and manufacturing of vaccine candidate against Chikungunya.
News
03 Jun 2020

Clinton Health Access Initiative, Inc. (CHAI) [to 6 June 2020]
https://clintonhealthaccess.org/
News & Press Releases
No new digest content identified.

EDCTP [to 6 June 2020]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.

Emory Vaccine Center [to 6 June 2020]
http://www.vaccines.emory.edu/
No new digest content identified.

European Medicines Agency [to 6 June 2020]
http://www.ema.europa.eu/ema/
News & Press Releases 
News: Patients’ and healthcare professionals’ organisations updated on EMA’s response to COVID-19
Last updated: 04/06/2020

European Vaccine Initiative [to 6 June 2020]
http://www.euvaccine.eu/news-events
Latest News
No new digest content identified.

FDA [to 6 June 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
June 5, 2020 – Coronavirus (COVID-19) Update: Daily Roundup June 5, 2020

June 4, 2020 – Coronavirus (COVID-19) Update: Daily Roundup June 4, 2020

June 4, 2020 – Coronavirus (COVID-19) Update: FDA Publicly Shares Antibody Test Performance Data From Kits as Part of Validation Study

June 4, 2020 – FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

June 3, 2020 – Coronavirus (COVID-19) Update: Daily Roundup June 3, 2020

June 2, 2020 – Coronavirus (COVID-19) Update: Daily Roundup June 2, 2020

June 1, 2020 – Coronavirus (COVID-19) Update: FDA Takes Action to Protect Public Health; Increase Supply of Alcohol-Based Hand Sanitizer

June 1, 2020 – Coronavirus (COVID-19) Update: Daily Roundup June 1, 2020

Fondation Merieux [to 6 June 2020]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.

Gavi [to 6 June 2020]
https://www.gavi.org/
News releases
4 June 2020
World leaders make historic commitments to provide equal access to vaccines for all
[See Milestones above for detail]

4 June 2020
Gavi launches innovative financing mechanism for access to COVID-19 vaccines
[See Milestones above for detail]

3 June 2020
HPV vaccine manufacturers commit to provide enough supply to immunise at least 84 million girls in Gavi countries
[See Milestones above for detail]

3 June 2020
Private sector partners strengthen Gavi programmes with more than US$ 70 million in contributions

1 June 2020
Switzerland commits CHF 30 million to Gavi

1 June 2020
Italy deepens support for Gavi with €150 million IFFIm pledge

1 June 2020
Gavi receives US$ 5 million from The Rockefeller Foundation
1 June 2020
The UPS Foundation commits US$ 3 million to Gavi

1 June 2020
New donor Greece pledges €1.5 million to Gavi COVID response

GHIT Fund [to 6 June 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.

Global Fund [to 6 June 2020]
https://www.theglobalfund.org/en/news/
Voices
On the Front Lines: Responding to COVID-19
04 June 2020
With personal protective equipment, radio broadcasts and innovative mosquito net campaigns, countries are fighting COVID-19, shoring up health systems, and mitigating the impacts on lifesaving HIV, TB and malaria. The Global Fund is supporting these efforts with immediate funding. Here’s where countries are directing that financial support to help stop the pandemic that threatens us all by uniting to fight…

Voices
Sex Workers in Africa Are More Vulnerable During COVID-19
04 June 2020

Hilleman Laboratories [to 6 June 2020]
http://www.hillemanlabs.org/
No new digest content identified.

Human Vaccines Project [to 6 June 2020]
http://www.humanvaccinesproject.org/media/press-releases/
No new digest content identified.

IAVI [to 6 June 2020]
https://www.iavi.org/newsroom
Press Releases
No new digest content identified.

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

IFFIm
http://www.iffim.org/
Press Releases
Italy deepens support for Gavi with €150 million IFFIm pledge
01 Jun 2020
Pledge follows €120 million in direct funding to Gavi Italy announced at last month’s Coronavirus Global Response pledging conference The funding builds on Italy’s previous investments in Gavi’s innovative financial tools –  IFFIm and the Advance Market Commitment Gavi’s record

IFRC [to 6 June 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Global
Joint statement: Uniting for a people’s vaccine against COVID-19
New York/Geneva, 3 June 2020 – The United Nations and the International Red Cross and Red Crescent Movement call for unity to scale up efforts to develop, test, and scale up production of safe, effective, quality, affordable diagnostics, therapeutics, …
3 June 2020

Africa, Democratic Republic of the Congo
DR Congo: Red Cross calls for “swift and extensive” response to the new Ebola outbreak
Goma/Nairobi/Geneva, 3 June 2020 –More than 150 trained Red Cross volunteers have been deployed as part of a first wave of response to the latest Ebola outbreak in the Équateur Province, in the western part of Democratic Republic of the Congo. Dr Simon …
3 June 2020

Africa, Global
Facebook and Red Cross Launch #AfricaTogether, a Campaign Calling for Vigilance against Covid-19
Nairobi/Geneva 01 June 2020 –Facebook and the International Red Cross and Red Crescent Movement are partnering to launch #AfricaTogether – a digital campaign and two-day festival on June 4th and 5th featuring artists from across Africa to encourage co …
1 June 2020

IVAC [to 6 June 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
Webinar: How will a COVID-19 Vaccine be Delivered?
June 2020
Register: The International Vaccine Access Center (IVAC) on June 17, 2020 at 1pm ET will host a 60-minute webinar, “How will a COVID-19 Vaccine be Delivered?“. Description: When a COVID-19 vaccine becomes available, it will effectively stop disease transmission only if it reaches the people who need it. Many decisions go into developing a strategy […]

IVI [to 6 June 2020]
http://www.ivi.int/
Selected IVI News & Announcements
IVI partners with Seoul National University Hospital to start Phase 1/2 clinical trial of INOVIO’s COVID-19 DNA (INO-4800) vaccine in South Korea
:: First COVID-19 vaccine clinical study approved in South Korea funded by CEPI through INOVIO, and supported by KCDC/KNIH
:: 2-stage trial to test INOVIO’s COVID-19 vaccine (INO-4800) using well-established DNA platform technology in adults
June 4, 2020, SEOUL, Korea and PLYMOUTH MEETING, PA, USA – The International Vaccine Institute (IVI) and Seoul National University Hospital announced a partnership to start a Phase 1/2 clinical trial of INO-4800 INOVIO’s (NASDAQ:INO) COVID-19 vaccine in South Korea at a signing ceremony today. In attendance at the ceremony at SNU Hospital were IVI’s Director General Dr. Jerome Kim and Deputy Director General of Science Dr. Manki Song, Dr. Anh Wartel (Associate Director General of EPIC and Head of Clinical Development and Regulatory) and Dr. Daniel Chul Woo Rhee (Project Lead), and SNU Hospital’s President Yon Su Kim and Prof. Myoung-don Oh…

CEPI awards up to US$14.1million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
June 3 2020, Oslo, Norway; Seoul, South Korea; Telangana, India—CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, has announced a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of a Chikungunya vaccine. CEPI will provide the consortium with up to US$14.1 million for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine (BBV87) against Chikungunya. This award is supported by the European Union’s (EU’s) Horizon 2020 programme through an existing framework partnership agreement with CEPI.
The consortium will be further supported with a grant of up to $2.0m from the Indian Government’s Ind-CEPI initiative which will fund the set-up of GMP manufacturing facilities for the vaccine in India, and the subsequent manufacture of clinical trial materials. In addition to manufacturing, the partnering agreement will finance a multi-centre Phase 2/3 adaptive clinical trial to be conducted by IVI in Colombia, Panama and Thailand which will provide crucial data about the safety and immunogenicity of the vaccine candidate.

The partnership will build on BBIL’s experience of developing and supplying affordable vaccines, and WHO prequalification procedures, to ensure affordable access to the vaccine in countries where Chikungunya is endemic, in line with CEPI’s core commitment to equitable access..

JEE Alliance [to 6 June 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

MSF/Médecins Sans Frontières [to 6 June 2020]
http://www.msf.org/
Latest [Selected Announcements]
Coronavirus COVID-19 pandemic
COVID-19 cases in Haiti spike dramatically as MSF …
Project Update 5 Jun 2020

Burkina Faso
Out of sight, people suffer from rise in violence in eastern B…
Op-Ed 5 Jun 2020

Mozambique
Thousands displaced, healthcare jeopardised, as violence surges in …
Press Release 5 Jun 2020

Democratic Republic of Congo
Nearly 200,000 people forced from homes as violence surges in no…
Press Release 4 Jun 2020

DRC Ebola outbreaks
Crisis update – June 2020
Crisis Update 4 Jun 2020

Coronavirus COVID-19 pandemic
Facing multiple challenges in responding to COVID…
Project Update 3 Jun 2020

Coronavirus COVID-19 pandemic
Any future COVID-19 vaccines must be sold at cost and accessible to all …
Press Release 3 Jun 2020
:: MSF has urged world leaders to demand pharmaceutical companies to sell any COVID-19 vaccines they develop at cost price.
:: The call comes as Gavi prepares to set up a fund specifically to pay for coronavirus vaccines for developing countries, into which governments are expected to pour in billions of dollars.
:: Governments must also overcome any nationalistic interests, and instead agree to distribute vaccinces based on equitable need, including to frontline health workers as a priority.

Coronavirus COVID-19 pandemic
MSF opens two COVID-19 treatment centres in northeastern Mexico…
Project Update 3 Jun 2020

Afghanistan
Fifteen mothers confirmed killed in Kabul maternity win…
Project Update 3 Jun 2020

Coronavirus COVID-19 pandemic
“We have a lot of people that die quickly” of COVID-19 in Yemen
Project Update 2 Jun 2020

Hepatitis C
Increasing access to hepatitis C treatment in Ukraine
Project Update 2 Jun 2020

National Vaccine Program Office – U.S. HHS [to 6 June 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC 2020 Meetings
June 9-10, 2020 NVAC Meeting (Virtual)
September 23-24, 2020 Meeting (Virtual)

NIH [to 6 June 2020]
http://www.nih.gov/news-events/news-releases
Selected News Releases
Study identifies potential approach to treat severe respiratory distress in patients with COVID-19
June 5, 2020 — These findings should not be considered clinical advice but are being shared to assist the public health response to COVID-19

NIH to test one-dose antibiotic for the prevention of maternal and infant sepsis
June 3, 2020 — Study of pregnant women in low- and middle-income countries co-funded by Bill & Melinda Gates Foundation.

PATH [to 6 June 2020]
https://www.path.org/media-center/
Selected Announcements
PATH CEO urges US to re-commit to WHO
May 30, 2020 by Nikolaj Gilbert
On behalf of my colleagues at PATH, I am disappointed by the news that the United States is withdrawing from the World Health Organization. It is precisely moments like these that demonstrate the need for the WHO’s existence. While we must all evaluate our role in the COVID-19 response with a critical eye for opportunities to improve, now is not the time to create further disruption. Ending support and collaboration during a pandemic threatens our ability to defeat it, and is harmful for the health of Americans and populations around the globe…

Sabin Vaccine Institute [to 6 June 2020]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
Amid COVID-19 Vaccine Race, Sabin Vaccine Institute and the Aspen Institute Release Report on Vaccine Hesitancy; A Call to Improve Vaccine Acceptance
Tuesday, June 2, 2020
New report delves into the role of misinformation in shaping vaccination behavior and provides bold, actionable recommendations to counter growing trend of vaccine hesitancy
Washington, D.C. — As the COVID-19 vaccine race accelerates, experts recognize that the challenge will not end with the development of a vaccine. The extraordinary effort to make a vaccine available across the globe will only be effective if the majority of people achieve immunity through vaccination. “Meeting the Challenge of Vaccination Hesitancy,” a new report released today by the Sabin-Aspen Vaccine Science and Policy Group, calls for an urgent, coordinated effort to strengthen vaccine acceptance and address the risk that vaccination hesitancy – the reluctance or opposition to vaccination despite the availability of safe and effective vaccines – poses to communities around the world…

UNAIDS [to 6 June 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
5 June 2020
The value of integrating HIV prevention and contraceptive services

4 June 2020
Mitigating the impact of COVID-19 on key populations

3 June 2020
Lessons learned from HIV for COVID-19 in Senegal

2 June 2020
Mobilizing COVID-19 relief for transgender sex workers in Guyana and Suriname

1 June 2020
“We cannot provide only HIV services while sex workers are hungry”: Thai community organization steps in

UNICEF [to 6 June 2020]
https://www.unicef.org/media/press-releases
Selected Press releases/Announcements
Press release
COVID-19: One third of youth in Latin America and the Caribbean believe they are not at risk from disease, new UNICEF poll shows
05/06/2020

Press release
Unequal access to remote schooling amid COVID-19 threatens to deepen global learning crisis
04/06/2020

Press release
HPV vaccine manufacturers commit to provide enough supply to immunize at least 84 million girls in Gavi countries
On the eve of the Global Vaccine Summit 2020, five manufacturers commit to increasing and prioritising HPV vaccine supply to Gavi-supported countries, which have among the highest cervical cancer burdens in the world
04/06/2020

Statement
Message from UNICEF Executive Director Henrietta Fore to staff
03/06/2020

Statement
Remarks by UNICEF Executive Director Henrietta Fore at the High-Level Pledging Event for the Humanitarian Crisis in Yemen
02/06/2020

Press release
Ebola resurfaces in Équateur Province, north-western Democratic Republic of the Congo
15-year-old girl among five victims of new outbreak as country battles Ebola, COVID-19 and measles
01/06/2020

Unitaid [to 6 June 2020]
https://unitaid.org/
Featured News
No new digest content identified.

Vaccination Acceptance Research Network (VARN) [to 6 June 2020]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.

Vaccine Confidence Project [to 6 June 2020]
http://www.vaccineconfidence.org/
Latest News & Archive
When a Close Friend Has Doubts About Vaccinations
5 Jun 2020

Coronavirus vaccine: anti-vax movement threatens Asian recovery
3 Jun 2020

Vaccine Education Center – Children’s Hospital of Philadelphia [to 6 June 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.

Wellcome Trust [to 6 June 2020]
https://wellcome.ac.uk/news
Explainer | 3 June 2020
The vaccine journey: from idea to immunisation
Researchers may well identify a safe, effective vaccine for COVID-19 before too long, but all that fantastic work could count for nothing unless we also invest in manufacturing and delivery – to make sure that there is enough of the vaccine available to everyone who needs it.

Opinion | 1 June 2020
While we wait for a COVID-19 vaccine, let’s not forget the importance of the vaccines we already have
Charlie Weller, Head of Vaccines Programme, Wellcome
With measures to prevent the spread of COVID-19 disrupting childhood and mass immunisation around the globe, millions are now at risk of other deadly diseases. This is why we must act and invest urgently to maintain routine immunisation.

The Wistar Institute [to 6 June 2020]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.

WFPHA: World Federation of Public Health Associations [to 6 June 2020]
https://www.wfpha.org/
Latest News
No new digest content identified.

World Organisation for Animal Health (OIE) [to 6 June 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
Press Releases
No new digest content identified.

::::::

ARM [Alliance for Regenerative Medicine] [to 6 June 2020]
https://alliancerm.org/press-releases/
Press Releases
ARM Statement on Racial Inequality & Injustice
June 5, 2020

BIO [to 6 June 2020]
https://www.bio.org/press-releases
Press Releases
BIO’s Dr. McMurry-Heath Says Racism a “Chronic Disease” Plaguing Society
June 4, 2020
Will lead discussion on race and equity with industry leaders Drs. Tony Coles, Ted Love, and Jeremy Levin next week In the wake of tragic deaths and civil unrest, BIO’s President and CEO Dr. Michelle McMurry-Heath announced she will lead a panel…

DCVMN – Developing Country Vaccine Manufacturers Network [to 6 June 2020]
http://www.dcvmn.org/
News
DCVMN participated in GAVI Vaccine Summit together with world leaders to support the new COVAX-AMC
04th June 2020

IFPMA [to 6 June 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
Pharma pledges to continue 20 year partnership with Gavi, the Vaccine Alliance
04 June 2020
:: IFPMA members have worked for 20 years with Gavi to stem the ravages of childhood infectious diseases, helping vaccinate an entire generation of children so that they can thrive into adulthood and working to discover and increase access to new life-saving vaccines
:: At the Global Vaccine Summit, IFPMA and its members pledge to play their part in protecting the health of the next generation, with the broadest vaccine portfolio in history.
:: Solidarity and shared responsibility are embedded in working at unparalleled speed to develop and build manufacturing capacity and distribution networks to deploy a COVID-19 vaccine.

Biopharmaceutical Industry Statement at Gavi, the Vaccine Alliance – Global Vaccine Summit 2020
Geneva, 4 June 2020
Statement delivered by: Thomas Cueni, Director General of IFPMA, the International Federation of Pharmaceutical Manufacturers and Associations.
Today, we face the first global pandemic in living memory. Never before has there been so much hope placed in finding safe and effective vaccines, with the promise that no one is left behind.
IFPMA’s members have worked for 20 years with Gavi to stem the ravages of infectious diseases. NOW they are working at unparalleled speed to develop and build manufacturing capacity and distribution networks to deploy a COVID-19 vaccine in record time. The pace and progress of this work is unprecedented.
We are proud to be a founding partners of the Gavi Alliance and the Vaccines Accelerator and are fully committed to its goal to accelerate development, production, and equitable access to safe, effective, and affordable COVID-19 vaccines.
Be assured, we will deliver on the shared vision to leave no one behind and win the battle against COVID-19 together.

ICBA – International Council of Biotechnology Associations [to 6 June 2020]
https://internationalbiotech.org/
News
No new digest content identified.

PhRMA [to 6 June 2020]
http://www.phrma.org/
Selected Press Releases, Statements
The latest: What they are saying: Intellectual property protections critical as we work to defeat COVID-19
Tom Wilbur   |     June 5, 2020

Industry Watch [to 6 June 2020]
:: Covid-19 Diagnostics Market to Reach $445.4 Mn, Globally, by the Fourth Quarter of 2020: Allied Market Research Jun 01, 2020

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

American Journal of Infection Control
June 2020 Volume 48, Issue 6, p591-732
http://www.ajicjournal.org/current

Major Articles
A qualitative study on the psychological experience of caregivers of COVID-19 patients
Niuniu Sun, Luoqun Wei, Suling Shi, Dandan Jiao, Runluo Song, Lili Ma, Hongwei Wang, Chao Wang, Zhaoguo Wang, Yanli You, Shuhua Liu, Hongyun Wang
p592–598
Published online: April 7, 2020

American Journal of Infection Control
June 2020 Volume 48, Issue 6, p591-732
http://www.ajicjournal.org/current

Examining the inclusion of patients and their family members in infection prevention and control policies and guidelines across Bangladesh, Indonesia, and South Korea
Ji Yeon Park, Jerico Franciscus Pardosi, Holly Seale
p599–608
Published online: January 13, 2020

American Journal of Infection Control
June 2020 Volume 48, Issue 6, p591-732
http://www.ajicjournal.org/current

Examining the inclusion of patients and their family members in infection prevention and control policies and guidelines across Bangladesh, Indonesia, and South Korea
Ji Yeon Park, Jerico Franciscus Pardosi, Holly Seale
p599–608
Published online: January 13, 2020

American Journal of Preventive Medicine
June 2020 Volume 58, Issue 6, p757-898
http://www.ajpmonline.org/current

Current Issues
COVID-19 and the Correctional Environment: The American Prison as a Focal Point for Public Health
Andre G. Montoya-Barthelemy, Charles D. Lee, Dave R. Cundiff, Eric B. Smith
p888–891
Published online: April 17, 2020

American Journal of Preventive Medicine
June 2020 Volume 58, Issue 6, p757-898
http://www.ajpmonline.org/current

Vulnerable Populations: Weathering the Pandemic Storm
Elizabeth M. Salisbury-Afshar, Josiah D. Rich, Eli Y. Adashi
p892–894
Published online: April 21, 2020

American Journal of Public Health
June 2020 110(6)
http://ajph.aphapublications.org/toc/ajph/current

COCHRANE
New Standards for Systematic Reviews Incorporate Population Health Sciences
Statistics/Evaluation/Research, Other Statistics/Evaluation/Research
Mona Nasser
110(6), pp. 753–754

American Journal of Public Health
June 2020 110(6)
http://ajph.aphapublications.org/toc/ajph/current

MIGRANTS HEALTH
Latest Public Health Threats to Migrants at the US Southern Border
Global Health, Government, Refugees, Immigration, Injury/Emergency Care/Violence
Joseph Nwadiuko and Sural Shah

Annals of Internal Medicine
2 June 2020Volume 172, Issue 11
http://annals.org/aim/issue

Reviews
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2
A Narrative Review
FREE
Matthew P. Cheng, MDCM, Jesse Papenburg, MD, MSc, Michaël Desjardins, MD, … et al.
Diagnostic testing to identify infected persons is central to efforts to control the COVID-19 pandemic. This review synthesizes current knowledge of diagnostic options available to clinicians, highlights key gaps in current diagnostic capacity, and discusses potential solutions.

Annals of Internal Medicine
2 June 2020Volume 172, Issue 11
http://annals.org/aim/issue

Ideas and Opinions
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
FREE
Jinoos Yazdany, MD, MPH and Alfred H.J. Kim, MD, PhD
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for COVID-19. The authors of this commentary provide guidance for clinical decision making for patients with COVID-19 as well as for patients with rheumatologic conditions, such as systemic lupus erythematosus and rheumatoid arthritis.

BMJ Global Health
June 2020 – Volume 5 – 6
https://gh.bmj.com/content/5/6

Commentary
Protecting hard-won gains for mothers and newborns in low-income and middle-income countries in the face of COVID-19: call for a service safety net
(3 June, 2020)
Wendy Jane Graham, Bosede Afolabi, Lenka Benova, Oona Maeve Renee Campbell, Veronique Filippi, Annettee Nakimuli, Loveday Penn-Kekana, Gaurav Sharma, Uduak Okomo, Sandra Valongueiro, Peter Waiswa, Carine Ronsmans

BMJ Global Health
June 2020 – Volume 5 – 6
https://gh.bmj.com/content/5/6

Towards a socially just model: balancing hunger and response to the COVID-19 pandemic in Bangladesh
(1 June, 2020)
Sabina Faiz Rashid, Sally Theobald, Kim Ozano

BMJ Global Health
June 2020 – Volume 5 – 6
https://gh.bmj.com/content/5/6

Practice
Prioritising the role of community health workers in the COVID-19 response (4 June, 2020)
Madeleine Ballard, Emily Bancroft, Josh Nesbit, Ari Johnson, Isaac Holeman, Jennifer Foth, Debbie Rogers, Jane Yang, James Nardella, Helen Olsen, Mallika Raghavan, Raj Panjabi, Rebecca Alban, Serah Malaba, Molly Christiansen, Stephanie Rapp, Jennifer Schechter, Patrick Aylward, Ash Rogers, Jacques Sebisaho, Clarise Ako, Nandini Choudhury, Carey Westgate, Julius Mbeya, Ryan Schwarz, Matthew H Bonds, Rehan Adamjee, Julia Bishop, Amanda Yembrick, David Flood, Meg McLaughlin, Daniel Palazuelos

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 6 June 2020)

An evidence mapping and analysis of registered COVID-19 clinical trials in China
This article aims to summarize the key characteristics of registered trials of 2019 novel coronavirus (COVID-19), in terms of their spatial and temporal distributions, types of design and interventions, and pa…
Authors: Liming Lu, Fan Li, Hao Wen, Shuqi Ge, Jingchun Zeng, Wen Luo, Lai Wang, Chunzhi Tang and Nenggui Xu
Citation: BMC Medicine 2020 18:167
Content type: Research article
Published on: 1 June 2020

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 6 June 2020)

Global health systems partnerships: a mixed methods analysis of Mozambique’s HPV vaccine delivery network actors
Global health partnerships have expanded exponentially in the last two decades with Gavi, the Vaccine Alliance considered the model’s pioneer and leader because of its vaccination programs’ implementation mech…
Authors: Caroline Soi, Jessica Shearer, Baltazar Chilundo, Vasco Muchanga, Luisa Matsinhe, Sarah Gimbel and Kenneth Sherr
Citation: BMC Public Health 2020 20:862
Content type: Research article
Published on: 5 June 2020

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 6 June 2020)

Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone
Immunization of women during pregnancy to protect them and their infants against tetanus, pertussis and influenza is recommended by the World health Organization (WHO). However, there is limited information ab…
Authors: Sanni Yaya, Komlan Kota, Amos Buh and Ghose Bishwajit
Citation: BMC Public Health 2020 20:855
Content type: Research article
Published on: 5 June 2020

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 6 June 2020)

Preferential differences in vaccination decision-making for oneself or one’s child in The Netherlands: a discrete choice experiment
To optimize the focus of future public information campaigns in The Netherlands promoting the uptake of vaccines among adults and children, we quantified the contribution of several attributes to the vaccinati…
Authors: Joram Hoogink, Frederik Verelst, Roselinde Kessels, Albert Jan van Hoek, Aura Timen, Lander Willem, Philippe Beutels, Jacco Wallinga and G. Ardine de Wit
Citation: BMC Public Health 2020 20:828
Content type: Research article
Published on: 1 June 2020

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 6 June 2020)

Feasibility of a twitter campaign to promote HPV vaccine uptake among racially/ethnically diverse young adult women living in public housing
Uptake and completion of the HPV vaccine is suboptimal. This study assessed the feasibility of implementing a one-month Twitter campaign to promote knowledge about the human papillomavirus (HPV) vaccine among …
Authors: Jennifer D. Allen, Justin Hollander, Lisa Gualtieri, Tania M. Alarcon Falconi, Stephanie Savir and Madina Agénor
Citation: BMC Public Health 2020 20:830
Content type: Research article
Published on: 1 June 2020

Bulletin of the World Health Organization
Volume 98, Number 6, June 2020, 373-440
https://www.who.int/bulletin/volumes/98/6/en/

EDITORIALS
Mortality surveillance during the COVID-19 pandemic
— Philip Setel, Carla AbouZahr, Emily B Atuheire, Martin Bratschi, Emily Cercone, Oliver Chinganya, Benjamin Clapham, Samuel J Clark, Carlie Congdon, Don de Savigny, Adam Karpati, Erin Nichols, Robert Jakob, James Mwanza, William Muhwava, Petra Nahmias, Elizabeth M Ortiz & Akhona Tshangela
http://dx.doi.org/10.2471/BLT.20.263194

Bulletin of the World Health Organization
Volume 98, Number 6, June 2020, 373-440
https://www.who.int/bulletin/volumes/98/6/en/

RESEARCH
A survey of nongovernmental organizations on their use of WHO’s prequalification programme
— Ariadna Nebot Giralt, Maya Ronse & Raffaella Ravinetto
http://dx.doi.org/10.2471/BLT.19.233882

Contemporary Clinical Trials
Volume 92 May 2020
https://www.sciencedirect.com/journal/contemporary-clinical-trials/vol/92/suppl/C

Research article Abstract only
Use of real-world data for HPV vaccine trial follow-up in the Nordic region
Espen Enerly, Sophie Berger, Susanne K. Kjær, Karin Sundström, … Mari Nygård
Article 105996

EMBO Reports
Volume 21 Issue 6 4 June 2020
https://www.embopress.org/toc/14693178/current

The evolving landscape around genome editing in agriculture : Many countries have exempted or move to exempt forms of genome editing from GMO regulation of crop plants
Sarah M Schmidt, Melinda Belisle, Wolf B Frommer

The EU and New Zealand are the only legislations where genome‐edited plants are considered and regulated as GMO s while many other countries move to exempt genome‐edited crops.

Emerging Infectious Diseases
Volume 26, Number 6—June 2020
http://wwwnc.cdc.gov/eid/

Perspective
Identifying and Interrupting Superspreading Events—Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2 [PDF – 334 KB – 8 pages]
T. R. Frieden and C. T. Lee

Health Affairs
Vol. 39, No. 6 June 2020
https://www.healthaffairs.org/toc/hlthaff/current

Rural Health, Behavioral Health & More
Research Article COVID-19
The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States
Sarah M. Bartsch, Marie C. Ferguson, James A. McKinnell, Kelly J. O’Shea,

Health Research Policy and Systems
http://www.health-policy-systems.com/content
[Accessed 6 June 2020]

Amplifying the role of knowledge translation platforms in the COVID-19 pandemic response
The COVID-19 pandemic presents the worst public health crisis in recent history. The response to the COVID-19 pandemic has been challenged by many factors, including scientific uncertainties, scarcity of relev…
Authors: Fadi El-Jardali, Lama Bou-Karroum and Racha Fadlallah
Citation: Health Research Policy and Systems 2020 18:58
Content type: Commentary
Published on: 3 June 2020

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 5, 2020
http://www.tandfonline.com/toc/khvi20/current

Special Issue: Vaccine Acceptance
Editorials
Building vaccine acceptance through communication and advocacy
Kristen A. Feemster
Pages 1004-1006 | Published online: 13 May 2020
…Conclusion
The key issues for increasing the number of vaccinated people worldwide, especially children, is to increase the supply of available vaccines, assure funding and affordability for lower-income countries, improve distribution and storage networks, assure the availability of healthcare workers to administer vaccines, improve the ability of the population to access vaccination centers, and minimize refusal / hesitation to maximize acceptability of vaccines.
It is noteworthy that among these key issues, all involve physical activities except for the final issue, which is the subject of this Special Issue. Vaccine acceptance / hesitation / refusal is unique in being a state of mind for the potential vaccinee or caregiver, such that different methods must be applied to improve acceptability. The ability of workers in the field to improve acceptability will be directly reflected in increased vaccinations with concomitant reductions in morbidity and mortality from vaccine-preventable diseases. This is a major public health challenge for the coming decade and beyond, which also will be very important for the success of new vaccines in the development pipeline.

This Special Issue includes an extensive number of articles around this theme which we recommend be reviewed.

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 6 June 2020]

Factors associated with mobile phone ownership and potential use for rabies vaccination campaigns in southern Malawi
Rabies is a fatal but preventable viral disease, which causes an estimated 59 000 human deaths globally every year. The vast majority of human rabies cases are attributable to bites from infected domestic dogs…
Authors: Orla Marron, Gareth Thomas, Jordana L. Burdon Bailey, Dagmar Mayer, Paul O. Grossman, Frederic Lohr, Andy D. Gibson, Luke Gamble, Patrick Chikungwa, Julius Chulu, Ian G. Handel, Barend M. de C Bronsvoort, Richard J. Mellanby and Stella Mazeri
Citation: Infectious Diseases of Poverty 2020 9:62
Content type: Research Article
Published on: 5 June 2020

International Journal of Infectious Diseases
May 2020 Volume 94, p1-164
https://www.ijidonline.com/issue/S1201-9712(20)X0006-3

Coronavirus (COVID-19) Collection
Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS-CoV-2 to fragile health systems of southern hemisphere countries this winter?
Marc Mendelson
p32–33
Published online: March 17, 2020

International Journal of Infectious Diseases
May 2020 Volume 94, p1-164
https://www.ijidonline.com/issue/S1201-9712(20)X0006-3

COVID-19 travel restrictions and the International Health Regulations – Call for an open debate on easing of travel restrictions
Eskild Petersen, Brian McCloskey, David S. Hui, Richard Kock, Francine Ntoumi, Ziad A. Memish, Nathan Kapata, Esam I. Azhar, Marjorie Pollack, Larry C. Madoff, Davidson H. Hamer, Jean B. Nachega, N. Pshenichnaya, Alimuddin Zumla
p88–90
Published online: April 16, 2020

JAMA
June 2, 2020, Vol 323, No. 21, Pages 2111-2210
https://jamanetwork.com/journals/jama/currentissue

Viewpoint
COVID-19: Beyond Tomorrow
Choices for the “New Normal”
Donald M. Berwick, MD, MPP
free access has active quiz has multimedia has audio
JAMA. 2020;323(21):2125-2126. doi:10.1001/jama.2020.6949
In this Viewpoint, Donald Berwick summarizes the rapid changes the COVID-19 pandemic has wrought on the pace, scientific standards, delivery mechanisms, and working conditions of health care and how it has sharply increased awareness of the societal costs of poor public health preparedness and health inequities.

JAMA
June 2, 2020, Vol 323, No. 21, Pages 2111-2210
https://jamanetwork.com/journals/jama/currentissue

Editorial
COVID-19—Looking Beyond Tomorrow for Health Care and Society
Phil B. Fontanarosa, MD, MBA; Howard Bauchner, MD

JAMA
June 2, 2020, Vol 323, No. 21, Pages 2111-2210
https://jamanetwork.com/journals/jama/currentissue

Information Technology–Based Tracing Strategy in Response to COVID-19 in South Korea—Privacy Controversies
Sangchul Park, JSD; Gina Jeehyun Choi, JSD; Haksoo Ko, JD, PhD
free access
JAMA. 2020;323(21):2129-2130. doi:10.1001/jama.2020.6602
This Viewpoint discusses legal and privacy concerns raised by South Korea’s information technology (IT)–based containment of the COVID-19 pandemic and proposes use of aggregated rather than person-level data to protect the privacy of individuals while maintaining the effectiveness of public health measures.